medmix AG (MEDX) Stock Statistics & Valuation Metrics

medmix AG has a market cap or net worth of CHF437.38M. The enterprise value is ―.

medmix AG has 41,262,370 shares outstanding. The number of shares has decreased by -2.65% in one year.

medmix AG’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of medmix AG is -51.53. medmix AG’s PEG ratio is 0.43.

In the last 12 months, medmix AG had revenue of 483.90M and earned -7.40M in profits. Earnings per share was -0.17.

In the last 12 months, operating cash flow was 69.30M and capital expenditures -50.10M, giving a free cash flow of 19.20M billion.

medmix AG pays an annual dividend of CHF0.5, resulting in a dividend yield of 4.72%

medmix AG upcoming earnings date is Jul 23, 2025, TBA Not Confirmed.

medmix AG as a current ratio of 1.60, with Debt / Equity ratio of 74.11%

In the past 12 months, medmix AG has paid 0.00 in taxes.

medmix AG EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

medmix AG has CHF140.70M in cash and marketable securities with CHF363.90M in debt, giving a net cash position of CHF223.20M billion.

Gross margin is 32.58%, with operating margin of 2.67%, and net profit margin of -1.53%.

The average price target for medmix AG is ―, which is 11.43% higher than the current price. The consensus rating is ―